Who founded Numerion Labs?

Numerion Labs was founded by Alex Levy, Izhar Wallach in 2012.

Who are Numerion Labs's investors?

Numerion Labs's investors include B Capital Group, B4 Capital, DCVC (Data Collective), Y Combinator.

Where is Numerion Labs headquartered?

Numerion Labs is headquartered in San Francisco, US.

Numerion Labs

YC W15

San Francisco, US · Founded 2012 · 67 employees · 4 known investors

Find your way into Numerion Labs

138 people in our graph share verified history with the Numerion Labs team — schools, employers, funds. One of them is your warm intro.

Alex Kolicichunlockedknows Alex Levy · together at University of Toronto (overlapped)

×11knows the team · via University of Toronto

Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

Also known as Atomwise

AI & Machine Learning Biotech Healthtech Medical Devices AI-powered Drug Discovery Deep Learning Drug discovery OncologyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W15)

Numerion Labs was founded in 2012 by Alex Levy and Izhar Wallach.

Alex Levy inCo-Founder, COO2013–2018Alex Levy co-founded Atomwise, an AI-focused drug discovery company with significant pharmaceutical partnerships, and previously led a computer vision research lab at the University of Toronto's Computer Science Department. He is currently CEO and co-founder of Atmo, which applies AI to weather forecasting.

Izhar Wallach inFounderIzhar Wallach founded Numerion Labs, which applies machine learning and computational chemistry to accelerate drug development.

Steve WorlandinCEO

Pamela TsurudaVP, Biology

Mark Sabat inVP, Medicinal ChemistryMark Sabat is VP of Medicinal Chemistry at Numerion Labs. He brings over 19 years of pharmaceutical discovery experience across multiple therapeutic areas, with a track record in drug development including clinical advancement of molecules and published expertise in structure-based and fragment-based drug design methodologies.

Kate StaffordinVP, Machine Learning

Board

Robert Mittendorf

Adam Seabrook in 𝕏Partner at B4 Capital

Mike Varney

Kemal Malik

Investors · 4

B Capital GroupManhattan Beach · $10M – $50M

B4 Capital$10M – $50M

DCVC (Data Collective)Palo Alto · $5M – $25M

Y CombinatorSan Francisco · $500K

Competitors · 2

by search overlap

Atomic AI18 shared keywordsAtomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs. The company applies computational approaches to advance RNA therapeutics.

Recursion (NASDAQ: RXRX)17 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.

Companies competing with Numerion Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Numerion Labs do?: Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
Who founded Numerion Labs?: Numerion Labs was founded by Alex Levy, Izhar Wallach in 2012.
Who are Numerion Labs's investors?: Numerion Labs's investors include B Capital Group, B4 Capital, DCVC (Data Collective), Y Combinator.
Where is Numerion Labs headquartered?: Numerion Labs is headquartered in San Francisco, US.